Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
06 08 2022
06 08 2022
Historique:
received:
21
05
2021
accepted:
22
07
2022
entrez:
6
8
2022
pubmed:
7
8
2022
medline:
10
8
2022
Statut:
epublish
Résumé
The tumour stroma, and in particular the extracellular matrix (ECM), is a salient feature of solid tumours that plays a crucial role in shaping their progression. Many desmoplastic tumours including breast cancer involve the significant accumulation of type I collagen. However, recently it has become clear that the precise distribution and organisation of matrix molecules such as collagen I is equally as important in the tumour as their abundance. Cancer-associated fibroblasts (CAFs) coexist within breast cancer tissues and play both pro- and anti-tumourigenic roles through remodelling the ECM. Here, using temporal proteomic profiling of decellularized tumours, we interrogate the evolving matrisome during breast cancer progression. We identify 4 key matrisomal clusters, and pinpoint collagen type XII as a critical component that regulates collagen type I organisation. Through combining our proteomics with single-cell transcriptomics, and genetic manipulation models, we show how CAF-secreted collagen XII alters collagen I organisation to create a pro-invasive microenvironment supporting metastatic dissemination. Finally, we show in patient cohorts that collagen XII may represent an indicator of breast cancer patients at high risk of metastatic relapse.
Identifiants
pubmed: 35933466
doi: 10.1038/s41467-022-32255-7
pii: 10.1038/s41467-022-32255-7
pmc: PMC9357007
doi:
Substances chimiques
COL12A1 protein, human
0
Collagen Type I
0
Collagen Type XII
0
Collagen
9007-34-5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4587Informations de copyright
© 2022. The Author(s).
Références
Biophys J. 2005 Feb;88(2):1377-86
pubmed: 15533922
Cancers (Basel). 2019 Jun 01;11(6):
pubmed: 31159419
Cell. 2009 Nov 25;139(5):891-906
pubmed: 19931152
Semin Cancer Biol. 2005 Oct;15(5):329-41
pubmed: 15970443
J Cell Biol. 1997 Feb 10;136(3):729-43
pubmed: 9024701
Elife. 2021 Jun 09;10:
pubmed: 34106045
Trends Cancer. 2016 Jun;2(6):279-282
pubmed: 28741525
Breast Cancer Res. 2016 Jan 08;18(1):5
pubmed: 26747277
Dev Cell. 2019 May 6;49(3):332-346
pubmed: 31063753
Science. 2001 Nov 23;294(5547):1708-12
pubmed: 11721053
Mol Cell Proteomics. 2012 Apr;11(4):M111.014647
pubmed: 22159717
Cancer Cell. 2014 Jun 16;25(6):719-34
pubmed: 24856586
Breast Cancer Res. 2015 Jun 04;17:79
pubmed: 26040322
Oncogene. 2005 Feb 3;24(6):1104-10
pubmed: 15690056
Sci Rep. 2017 Dec 4;7(1):16887
pubmed: 29203823
Cancer Res. 2020 Apr 1;80(7):1461-1474
pubmed: 32029550
Breast Cancer Res. 2008;10(1):201
pubmed: 18226174
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Cancer Rep (Hoboken). 2020 Feb;3(1):e1209
pubmed: 32671954
Nat Commun. 2020 Sep 9;11(1):4520
pubmed: 32908154
Cancer Cell. 2014 Jun 16;25(6):735-47
pubmed: 24856585
Methods Cell Biol. 2020;156:109-160
pubmed: 32222216
Sci Adv. 2021 Oct;7(40):eabh0363
pubmed: 34586840
Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):E5625-E5634
pubmed: 28652369
Oncogene. 2021 Jan;40(3):475-491
pubmed: 33235291
J Clin Invest. 2020 Nov 2;130(11):5721-5737
pubmed: 32721948
Cancer Cell. 2021 Apr 12;39(4):548-565.e6
pubmed: 33667385
Am J Pathol. 2008 Sep;173(3):844-55
pubmed: 18688028
Cell Rep. 2021 Apr 13;35(2):108945
pubmed: 33852842
Elife. 2014 Mar 11;3:e01308
pubmed: 24618895
Cell. 2018 Feb 8;172(4):841-856.e16
pubmed: 29395328
Trends Biochem Sci. 1991 May;16(5):191-4
pubmed: 1882421
Nat Rev Mol Cell Biol. 2014 Dec;15(12):771-85
pubmed: 25370693
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
BMC Med. 2006 Dec 26;4(1):38
pubmed: 17190588
Oncotarget. 2012 Mar;3(3):267-85
pubmed: 22408128
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Mol Med Rep. 2019 Oct;20(4):3103-3112
pubmed: 31432110
Hum Mol Genet. 2014 May 1;23(9):2353-63
pubmed: 24334769
J Exp Med. 2021 May 3;218(5):
pubmed: 33822843
Mol Biol Cell. 2002 Oct;13(10):3546-59
pubmed: 12388756
Nat Med. 2017 Jul;23(7):890-898
pubmed: 28604702
J Clin Invest. 2021 Jun 1;131(11):
pubmed: 33905375
Cell Rep. 2021 Sep 14;36(11):109689
pubmed: 34525350
Nat Commun. 2021 Apr 20;12(1):2328
pubmed: 33879793
Dis Model Mech. 2011 Mar;4(2):165-78
pubmed: 21324931
Int J Biochem Cell Biol. 2014 Aug;53:51-4
pubmed: 24801612
Cancer Res. 2009 Aug 1;69(15):6339-46
pubmed: 19584278
Nat Protoc. 2012 Mar 08;7(4):654-69
pubmed: 22402635
Cell. 2020 Apr 16;181(2):486-486.e1
pubmed: 32302576
Nat Cell Biol. 2013 Jun;15(6):637-46
pubmed: 23708000
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
J Cell Biol. 2007 Dec 17;179(6):1311-23
pubmed: 18086923
Cell Rep. 2020 Jun 2;31(9):107701
pubmed: 32492417
Matrix Biol. 2021 Jan;95:52-67
pubmed: 33096204
Trends Cancer. 2019 Nov;5(11):724-741
pubmed: 31735290
Nat Commun. 2018 Jul 24;9(1):2897
pubmed: 30042390
N Engl J Med. 2007 Jan 18;356(3):227-36
pubmed: 17229950
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
Matrix Biol. 2020 Dec;94:57-76
pubmed: 32890632
Am J Pathol. 2022 Feb;192(2):308-319
pubmed: 34774848
Nature. 2021 Nov;599(7886):673-678
pubmed: 34732895
Cell. 2018 Apr 5;173(2):400-416.e11
pubmed: 29625055
Curr Protoc Cell Biol. 2016 Jun 01;71:10.9.1-10.9.34
pubmed: 27245425
J Histochem Cytochem. 2014 Oct;62(10):751-8
pubmed: 25023614
Histopathology. 2016 Jul;69(1):25-34
pubmed: 26588661
Nat Commun. 2019 Aug 12;10(1):3637
pubmed: 31406163
Breast Cancer Res. 2016 May 03;18(1):45
pubmed: 27142210
Biomaterials. 2017 Jun;128:147-159
pubmed: 28327460
J Proteome Res. 2017 Aug 4;16(8):3083-3091
pubmed: 28675934
Sci Transl Med. 2017 Apr 5;9(384):
pubmed: 28381539
Am J Pathol. 2011 Mar;178(3):1221-32
pubmed: 21356373
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Cancer Res. 2020 Apr 1;80(7):1475-1485
pubmed: 32019869
Curr Opin Cell Biol. 2016 Oct;42:80-93
pubmed: 27214794
BMC Med. 2008 Apr 28;6:11
pubmed: 18442412
N Engl J Med. 2002 Sep 19;347(12):886-94
pubmed: 12239257
Nat Cell Biol. 2021 Jul;23(7):758-770
pubmed: 34226698
J Biol Chem. 2006 Sep 15;281(37):27461-70
pubmed: 16861231
Mol Cell Proteomics. 2017 Dec;16(12):2296-2309
pubmed: 29070702
Matrix Biol Plus. 2020 Jan 20;6-7:100021
pubmed: 33543019
Nat Mater. 2021 Apr;20(4):548-559
pubmed: 33257795
Mol Cell Biol. 1992 Mar;12(3):954-61
pubmed: 1312220
Exp Cell Res. 2004 Aug 1;298(1):305-15
pubmed: 15242785
J Vis Exp. 2011 Oct 13;(56):e3089
pubmed: 22025017
EMBO J. 2020 Oct 1;39(19):e104063
pubmed: 32790115
Proc Natl Acad Sci U S A. 2019 Sep 24;116(39):19609-19618
pubmed: 31484774
Matrix Biol. 2020 Dec;94:77-94
pubmed: 32950601
Cancer Cell. 2019 Jan 14;35(1):64-80.e7
pubmed: 30612941
Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):138-145
pubmed: 29141852
Front Oncol. 2018 Sep 05;8:337
pubmed: 30234012
Nat Rev Cancer. 2021 Apr;21(4):217-238
pubmed: 33589810
Nat Protoc. 2019 Jan;14(1):68-85
pubmed: 30464214
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Cancer Med. 2020 Jul;9(13):4743-4755
pubmed: 32356618
J Cell Biochem. 2002;87(2):208-20
pubmed: 12244573
Histochem J. 1979 Jul;11(4):447-55
pubmed: 91593
J Biophotonics. 2010 Jan;3(1-2):34-43
pubmed: 19771581
Cancer Res. 2015 Mar 15;75(6):963-73
pubmed: 25600648